代谢领域喜讯不断!银诺医药港股上市,礼来13亿美元再布局减重,首款肝病疗法获批

医药经济报
Aug 17

1.银诺医药港股上市,开盘大涨285.44%8月15日,专注于糖尿病和其他代谢性疾病创新疗法的生物制药公司银诺医药成功在港交所主板上市,发行价格18.68港元/股 ,开盘价72港元/股,开盘大涨285.44%,市值达329亿港元。银诺医药成立于2014年12月5日,是一家专注于糖尿病和其他代谢性疾病创新疗法的生物制药公司。公司核心产品是针对GLP-1R靶点的依苏帕格鲁肽α,一款公司自主研发的人源...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10